| Literature DB >> 30902082 |
Hui Li1, Yumeng Huang1, Yan Li1, Baozhong Zheng1, Jingqiu Cui2, Ming Liu3.
Abstract
BACKGROUND: POEMS syndrome, a rare systemic disease, is characterized by 5 components: Peripheral neuropathy, Organomegaly, Endocrinopathy, M protein elevation, and Skin changes. It usually presents with multiplex endocrine manifestations and is easily misdiagnosed and incorrectly treated. CASEEntities:
Keywords: Endocrinopathy; Hyperpigmentation; POEMS syndrome; Plasmacytoma; Polyneuropathy
Mesh:
Year: 2019 PMID: 30902082 PMCID: PMC6431048 DOI: 10.1186/s12902-019-0355-6
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
Thyroid function of the patient
| Date | FT3 | FT4 | TSH | TGAb | TPOAb |
|---|---|---|---|---|---|
| 1st daya |
| 9.73 |
| < 20 | < 10 |
| 23rd daya |
| 9.25 |
| – | – |
| 8th montha |
| 12.85 | 1.557 | – | – |
| 9th monthb | 4.17 |
| 3.84 | – | – |
| 10th monthb | 4.79 |
| 3.11 | – | – |
| 12th monthb,c | 5.18 | 18.52 | 0.11 | – | – |
aReference range of one hospital, breference range of another hospital, c after lenalidomide was administered, boldface type indicate values out of range
Adrenal function of the patient
| Date | Cor | ACTH | 24 h urine Cor |
|---|---|---|---|
| 1st day | 21.6 |
| 49.72 |
| 8th month | 15.8 |
| 246.25 |
| 9th month | 11.4 |
| – |
| 10th month | 10.65 |
| – |
| 12th month | 11.51 | – | – |
aElevated level of ACTH, considered relatively adrenal insufficiency, bAfter hydrocortisone was administered, the ACTH level was elevated, boldface type indicate values out of range
Fig. 1Before diagnosis, misery and depression were visible from the patient’s face
Fig. 2Cutaneous pigmentation
Fig. 3Symmetrical edema of the double limbs
Fig. 4Severe edema of the left foot
Fig. 5Edema of the back of the hand
Fig. 6Edema of the upper limbs
Fig. 7After ASCT treatment, the patient gained weight
Comparison of endocrinopathy in different series
| Characteristics | Nakanishi et al.[ | Soubrier et al.,[ | Dispenzieri et al.,[ | Gandhi et al.,[ | Hu et al. [ | |
|---|---|---|---|---|---|---|
| Any endocrine abnormality | NR | NR | 66/99(66) | 54/64(84) | 22/23(96) | |
| Adrenal axis abnormality | NR | NR | 16/35(46) | 6/9(67) | 10/17(59) | |
| Hyperprolactinemia | NR | 4/17(24) | 5/25(20) | 10/35(29) | 9/15(60) | |
| Diabetes mellitus or glucose intolerance | 26/93(28) | 9/22(41) | 3/99(3) | 24/50(48) | 5/23(22) | |
| Hypothyroidism | 5/21(24) | 10/22(45) | 26/99(26) | 28/48(58) | 13/22(59) | |
| Hypocalcemia | NR | NR | 1/4(25) | 14/51(27) | 3/10(30) | |
| Gonad related dysfunction | Hypogonadism | NR | 9/19(47) | 55/99(55) | 26/33(79) | 7/18(39) |
| Erectile dysfunction (males) | 39/50(78) | 13/13(100) | 44/63(71) | 23/38(61) | NR | |
| Gynecomastia or galactorrhea (males) | 43/63(68) | 10/13(77) | 17/63(27) | 10/38(26) | NR | |
| Multiple endocrine abnormalities | NR | NR | NR | 29/54(54) | NR | |
*Data are number (percentage) of patients, NR = not reported